Zydus to begin phase-II (a) clinical trial of oral inflammasome inhibitor in patients with Cryopyrin-Associated Periodic Syndrome in Australia Read more
Panel discussion: Next gen pharma labs: Techniques, technology and adapting to rapid changes to pharma testings Read more